PreveCeutical Medical Ownership
| PRVCF Stock | USD 0.02 0 9.76% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
PreveCeutical |
PreveCeutical OTC Stock Ownership Analysis
About 24.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.0. PreveCeutical Medical last dividend was issued on the 14th of July 2017. The entity had 5:1 split on the 23rd of May 2018. PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada. Preveceutical Medical operates under Biotechnology classification in the United States and is traded on OTC Exchange.The quote for PreveCeutical Medical is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about PreveCeutical Medical contact Stephen Deventer at 604 416 7777 or learn more at https://www.preveceutical.com.Currently Active Assets on Macroaxis
Other Information on Investing in PreveCeutical OTC Stock
PreveCeutical Medical financial ratios help investors to determine whether PreveCeutical OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PreveCeutical with respect to the benefits of owning PreveCeutical Medical security.